CDC: Bad flu season has peaked in the United States
One of the worst flu seasons in years has reached its peak and is improving, officials with the Centers for Disease Control ...
Trump plans to sign executive order making English official United States language
According to multiple media reports Friday, President Donald Trump is expected to sign an executive order declaring English ...
After Extraordinary Step by Mexico, Drug Lord Appears in New York Court
The move by Mexico to allow the transfer of Rafael Caro Quintero to the United States signaled a potentially new era of ...
FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil
Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
Top Mexican prosecutor defends transfer of accused drug lords as legal
Mexican Attorney General Alejandro Gertz defended on Friday the legality of the government's handover of 29 suspected cartel ...
Mexico extradites drug lord linked to DEA murder
Among those extradited is Rafael Caro Quintero, who was convicted of the 1985 torture and murder of U.S. Drug Enforcement ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Trump's threats worked: Mexico extradited 29 drug lords to the United States
The Mexican authorities, amid threats of imposing 25 percent duties, handed over to the United States 29 drug lords who were ...
Morningstar6d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...